Drug Trial Radar · NCT01034774
Phase 1 Study to Determine Safety, Blood PK and Lung Penetration
Last checked: Nov 20, 2026Latest source record: Feb 27, 2012 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
40
Actual
Start
Jan 2010
Primary completion
Jun 2010
Study completion Jul 2010
Sponsor
- Lead sponsor
- Achaogen, Inc.Industry
- Sponsor type
- Industry
- First posted
- Dec 17, 2009
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Multiple center, double-blind, randomized, placebo-controlled study to see if it is safe to give ACHN-490 Injection for 5 consecutive days, to measure plasma pharmacokinetics, and to determine lung penetration of ACHN-490 (measured in ELF-epithelial lining fluid)after a single dose of ACHN-490 Injection in healthy volunteers.
Conditions
- Healthy Volunteers
Interventions
ACHN-490 InjectionDrug
ACHN-490 Injection at 15mg/kg is given either 1 or 5 consecutive days. Cohort 1 receives 5 consecutive days of treatment and Cohort 2 receives a single dose of treatment.
Placebo (normal saline)Drug
Placebo is given at the same volume as ACHN-490 Injection to maintain the blind.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Safety measured by reported adverse events after administering ACHN-490 Injection/placebo for 5 consecutive daysTime frame: Throughout the study
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.